Pat
J-GLOBAL ID:202303001058122906
新規フザラミン物質を有効成分とする白血病細胞増殖抑制剤
Inventor:
,
,
,
,
,
,
,
,
Applicant, Patent owner:
Agent (1):
名古屋国際弁理士法人
Gazette classification:特許公報
Application number (International application number):2019110891
Publication number (International publication number):2020164502
Patent number:7389448
Application date: Jun. 14, 2019
Publication date: Oct. 08, 2020
Claim (excerpt):
【請求項1】 下記式で表されるフザラミン物質若しくはその塩、又はその水和物若しくは溶媒和物。
IPC (7):
C07D 207/448 ( 200 6.01)
, A61K 31/4015 ( 200 6.01)
, A61K 36/06 ( 200 6.01)
, A61P 35/02 ( 200 6.01)
, A61P 31/04 ( 200 6.01)
, C12P 1/02 ( 200 6.01)
, C12N 1/14 ( 200 6.01)
FI (7):
C07D 207/448 CSP
, A61K 31/401
, A61K 36/06 Z
, A61P 35/02
, A61P 31/04
, C12P 1/02 Z
, C12N 1/14 A
Article cited by the Patent:
Cited by examiner (3)
-
Fungal Genetics and Biology, 2016, Vol. 89, p.37-51
-
Chemistry & Biodiversity, 2010, Vol. 7, No. 12, p.2830-2845
-
Organic & Biomolecular Chemistry, 2007, Vol. 5, No. 11, p.1702
Return to Previous Page